BSE | NSE

Zydus Lifesciences Ltd.

532321 ZYDUSLIFE Group (A)

26 Jul,15:29

1209.75
4.15 (0.34%)

HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist

Refresh

Zoom

Day

6Mn

Volume	Prev close	Day's H/L (Rs.)	52wk H/L (Rs.)	Mkt Cap (Rs. Cr)	Zydus Lifesciences Ltd. BUY SELL
19,478	1,205.60	1,214.95 - 1,197.00	1,203.20 - 564.05	121,725.05	Zydus Lifesciences Ltd. BUY SELL

News for Zydus Lifesciences Ltd.

Zydus Lifesciences Gets Mexican Nod for Cancer Biosimilar

Zydus Lifesciences secures Mexican regulatory approval for Bhava, a biosimilar cancer treatment, expanding its reach to Latin America. The drug is used for various cancers, including colorectal and...

Jul 22, 2024 11:30

Zydus Lifesciences Gets USFDA Nod for Diabetes Drug - Zituvimet XR

Zydus Lifesciences receives USFDA approval for its new drug application for Zituvimet XR (sitagliptin and metformin hydrochloride) extended-release tablets, a diabetes medication. This marks the...

Jul 19, 2024 12:16

USFDA Classifies Zydus Plant as 'Official Action Indicated'

USFDA has issued an 'Official Action Indicated' classification for Zydus Lifesciences's injectables plant in Gujarat, indicating potential regulatory action.

Jul 18, 2024 18:44

USFDA Classifies Zydus Lifesciences Jarod Unit 'OAI' - What It Means

USFDA classifies Zydus Lifesciences' Jarod injectables facility as 'Official Action Indicated' following inspection. Learn about the implications and what it means for the company.

Jul 18, 2024 17:55

Zydus Licenses Takeda's GERD Drug Vonoprazan for India

Zydus Lifesciences has signed a licensing deal with Takeda to market Vonoprazan, a P-CAB drug for GERD, in India under the brand name Vault.

Jul 17, 2024 17:59

More News for Zydus Lifesciences Ltd. »

(Rs. Crore)

Financial Results of Zydus Lifesciences Ltd.

	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20
Sales	10,818.70	8,731.60	7,981.90	7,790.40	6,347.40
Operating profit	4,058.70	2,454.40	1,918.10	2,319.10	1,423.10
Interest	390.70	278.20	134.90	70.90	233.90
Gross profit	4,752.80	2,724.60	1,961.90	2,327.10	2,038.60
EPS (Rs)	34.21	15.11	8.38	14.42	13.80

See more in Research Center »

Statements:Balance Sheet | P&L | Cash Flow

More:Dividend | Bonus | Share Holding | Capital Structures | Ratios

About Zydus Lifesciences Ltd.

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020. Wikipedia

News for Pharmaceuticals and health care

Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue

Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...

Jul 26, 2024 22:32

Sebi Confirms Order Against 12 in V Marc India Fraud

Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.

Jul 26, 2024 22:25

PM GatiShakti Evaluates 5 Infra Projects: Road, Rail

Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.

Jul 26, 2024 22:10

Fortune Wealth Targets Rs 500 cr Multi-Cap Fund

Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.

Jul 26, 2024 22:05

Kargil Vijay Diwas: India Post Releases Commemorative Stamp

India Post commemorates the 25th anniversary of Kargil Vijay Diwas with a special postage stamp, honoring the bravery of Indian armed forces.

Jul 26, 2024 22:04

More News »

Top News

G20 Agrees to Tax Super-Rich, Brazil Leads Effort

Finance ministers from G20 nations agree to work toward taxing the super-rich, a significant step toward addressing global inequality. Brazil's proposal for a 2% minimum tax on billionaires is...

Jul 27, 2024 03:35

Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue

Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...

Jul 26, 2024 22:32

Sebi Confirms Order Against 12 in V Marc India Fraud

Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.

Jul 26, 2024 22:25

PM GatiShakti Evaluates 5 Infra Projects: Road, Rail

Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.

Jul 26, 2024 22:10

Fortune Wealth Targets Rs 500 cr Multi-Cap Fund

Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.

Jul 26, 2024 22:05

More Top News »

Report Card

PE Ratios

35.36

EPS (Rs.)

34.21

Sales (Rs. Cr)

3,332.40

Face Value (Rs.)

Net Profit Margin (%)

31.81

Last Bonus

1:2

Last Dividend(%)

300

Return on Average Equity

21.89

BSE Announcements from Zydus Lifesciences Ltd. (See all)

Receipt Of An Order From State Tax Officer, M S Kutch, Div-12, Gandhidham - 1 day(s) ago

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation - 4 day(s) ago

Compare 'Zydus Lifesciences Ltd.' with other stocks

Sun Pharmaceutical Industries Ltd.
1,665.20
Compare

Cipla Ltd.
1,499.90
Compare

Divi's Laboratories Ltd.
4,549.75
Compare

Dr. Reddy's Laboratories Ltd.
6,854.20
Compare

Torrent Pharmaceuticals Ltd.
3,087.85
Compare

Apollo Hospitals Enterprise Ltd.
6,388.60
Compare

Max Healthcare Institute Ltd.
926.50
Compare

Lupin Ltd.
1,801.15
Compare

Alkem Laboratories Ltd.
5,178.80
Compare

Abbott India Ltd.
28,002.40
Compare

Mutual Funds Invested

Goldman Sachs CNX 500 Fund - Direct Plan - Growth

0.21%

Goldman Sachs CNX 500 Fund - Growth

0.21%

Goldman Sachs CNX 500 Fund - Direct Plan - Dividend

0.21%

Goldman Sachs CNX 500 Fund - Dividend

0.21%

Most Active

Change (Rs.)

Cipla Ltd.
78.35
(5.22%)

Aurobindo Pharma Ltd
24.05
(1.77%)

Lupin Ltd.
38.40
(2.13%)

Biocon Ltd.
6.90
(1.91%)

Glenmark Pharmaceuti
14.05
(0.99%)

Dexo Laboratories Lt
37.95
(0.55%)

Divi's Laborato
242.40
(5.33%)

Piramal Pharma Ltd.
0.25
(0.15%)

Wockhardt Ltd.
-8.95
(-1.04%)

Natco Pharma Ltd.
8.40
(0.63%)

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us

Add Zydus Lifesciences Ltd. to your Portfolio
Date of purchase
Quantity
Purchase price
Exchange	BSE BSE NSE NSE

Zydus Lifesciences Ltd.

Zydus Lifesciences Ltd.

News for Zydus Lifesciences Ltd.

Financial Results of Zydus Lifesciences Ltd.

About Zydus Lifesciences Ltd.

News for Pharmaceuticals and health care

Top News

Report Card

BSE Announcements from Zydus Lifesciences Ltd. (See all)

Compare 'Zydus Lifesciences Ltd.' with other stocks

Mutual Funds Invested

Most Active

REDIFFGURUS

I am 28 with monthly salary 70000 I have MF of...

My husband is 50 and I am 47. We have a combined...

I have hdfc small cap, multicap, flexicap funds all...

I am interested in investing 1 Lakh per month in...

Hello Sir,I am 32 yrs old, Engineer, Married,...

Sir I have invested in Jeevan Shanti 2 CR for 9...

Sir, I had initially started SIP in mutual funds via...

Zydus Lifesciences Ltd. performance snapshot

Peers

Stocks

Mutual Funds

Investment tracking

Add Zydus Lifesciences Ltd. to your Portfolio

Add Zydus Lifesciences Ltd. to your Watchlist

Add Zydus Lifesciences Ltd. to your Watchlist Alert me if price...
Goes above Rs.
Goes below Rs.